Jon Biorkman, MD
Family Medicine · Irvine, CANPI 1023008679
Payments from drug & device makers
Across 319 payments — averaging $20.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$906
- Boehringer Ingelheim$753
- Lilly USA, LLC$713
- GSK$694
- AbbVie$555
- Novo Nordisk$419
- plus $2K from 34 others
What the payments were for
- Food & beverage$6,478100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $906 |
| Boehringer Ingelheim | 34 | $753 |
| Lilly USA, LLC | 36 | $713 |
| GSK | 34 | $694 |
| AbbVie | 21 | $555 |
| Novo Nordisk | 20 | $419 |
| Pfizer | 23 | $412 |
| Amgen | 14 | $320 |
| Merck | 16 | $276 |
| Gilead | 6 | $158 |
| Sanofi Pasteur Inc. | 8 | $135 |
| Johnson & Johnson | 9 | $133 |
| Sanofi-aventis U.S. LLC | 8 | $125 |
| Idorsia Pharmaceuticals US Inc | 5 | $88 |
| Exact Sciences | 3 | $70 |
| SK Life Science, Inc. | 2 | $58 |
| Neurocrine Biosciences, Inc. | 2 | $49 |
| Lucid Diagnostics Inc. | 2 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $45 |
| UCB, Inc. | 1 | $42 |
| Medtronic(2 entities) | 2 | $41 |
| MDD US Operations, LLC | 2 | $39 |
| Seqirus USA Inc | 2 | $37 |
| Averitas Pharma Inc. | 1 | $32 |
| Tanabe Pharma America, Inc. | 1 | $29 |
| Biogen | 1 | $28 |
| Mayne Pharma Commercial LLC | 1 | $27 |
| Bausch Health US, LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $24 |
| Kaleo, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Metuchen Pharmaceuticals | 1 | $19 |
| Abbott | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $13 |
How this compares
$6,484 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 96 | $1,239 |
| Atorvastatin Calcium | 103 | $1,200 |
| Donepezil Hcl | 13 | $812 |
| ValacyclovirValacyclovir Hcl | 13 | $568 |
| Rosuvastatin Calcium | 27 | $508 |
| Losartan Potassium | 57 | $489 |
| Metformin Hcl | 50 | $489 |
| Omeprazole | 34 | $452 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $445 |
| Tamsulosin Hcl | 22 | $330 |
| Metoprolol Succinate | 17 | $319 |
| Pantoprazole Sodium | 25 | $287 |
| Amlodipine Besylate | 64 | $256 |
| Benazepril Hcl | 31 | $236 |
| Zolpidem Tartrate | 48 | $229 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Irvine
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.